Essence Pharma: Subsidiary Nantong Company Obtains Notification of Approval for Lopinavir "Chemical Raw Material Drug Listing Application"

Essence Pharmaceutical announced that its subsidiary Nantong Company has recently obtained the approval notice for the marketing application of Ritonavir chemical raw materials issued by the National Medical Products Administration. The notice number is 2025YS00593, registration number is Y20230001302, and acceptance number is CYHS2460104. Ritonavir is a chemical raw material used as an antiviral drug mainly for the treatment of AIDS. During the COVID-19 pandemic, Ritonavir is also one of the main drugs used for treating COVID-19.